Search bioRxiv⌕ Search

Biology subjects

Stöckl, J. B.

Publications and source records attributed to Stöckl, J. B..

3 recordsLinked to original sources

Phosphoproteomics in Daphnia magna as a tool to decipher molecular mechanisms in ecotoxicological studies

Pollution of aquatic environments poses an increasingly severe threat to ecosystems worldwide, and understanding its molecular consequences for aquatic organisms requires extensive research and the development of advanced analytical tools. Phosphoproteomics can be particularly valuable for this purpose, as shifts in phosphorylation states can serve as early molecular indicators of toxic exposure. The cladoceran Daphnia is a keystone species in aquatic ecosystems, linking lower and higher trophic levels, and is therefore widely used as a model organism in ecotoxicology to study biological consequences of pollution. Here, we present a simple and effective strategy to analyse the phosphoproteome of Daphnia magna, a commonly used Daphnia species in ecotoxicology. Following TiO2-based phosphopeptide enrichment and LC-MS/MS analysis, we identified a comprehensive dataset of 3,532 phosphorylation sites across 1,329 phosphoproteins. These proteins were especially involved in signaling pathways and cellular structure and the vast majority have not yet been demonstrated in other Daphnia species. In conclusion, our results demonstrate that a straightforward phosphoproteomic LC-MS/MS workflow in D. magna can serve as a powerful tool for investigating adverse molecular effects caused by anthropogenic pollution, such as microplastics or pharmaceuticals. Statement of significanceThe dataset presented here demonstrates the feasibility of a simple yet effective strategy to perform phosphoprotemics in Daphnia magna, and it will be particularly valuable for future ecotoxicoproteomics research using this model organism.

pharmacology and toxicology↗

Multi-modal analysis of satellite cells reveals early impairments at pre-contractile stages of myogenesis in Duchenne muscular dystrophy

Recent studies on the role of myogenic satellite cells (SC) in Duchenne muscular dystrophy (DMD) documented altered division capacities and impaired regeneration potential of SC in DMD patients and animal models. It remains unknown, however, if SC-intrinsic effects trigger these deficiencies at pre-contractile stages of myogenesis rather than resulting from the pathologic environment. Addressing this, we isolated SC from muscle biopsies of a porcine DMD model for characterization. Traction force microscopy (TFM) revealed that DMD SC produce a significantly higher strain energy than wild-type cells (WT; 0.136 {+/-} 0.016 {micro}J vs. 0.057 {+/-} 0.008 {micro}J). By RNA-seq, we identified 1,390 differentially expressed genes and proteomics measurements detected 1,261 proteins with altered abundance in DMD vs. WT. Dysregulated pathways uncovered by Gene Ontology (GO) enrichment analysis included sarcomere organization, focal adhesion, and response to hypoxia. We integrated the data using multi-omics factor analysis (MOFA) and identified five factors accounting for the variance with an overall higher contribution of the transcriptomic (61.95 %) than the proteomic data (54.02 %). Our findings suggest SC impairments result from their inherent genetic abnormality rather than environmental influences. The observed biological changes are independent and not reactive to the pathological surrounding of DMD muscle.

pathology↗

Gene Therapy for Cardiomyopathy associated with Duchenne Muscular Dystrophy in a Pig Model

BackgroundGenetic cardiomyopathies caused by mutations in the dystrophin gene (DMD) are only partially responsive to current pharmacological heart failure treatments, although dilated and arrhythomogenic phenotypes of cardiomyopathy are frequent. ObjectiveIn this study, we tested whether a normalization of Ca2+-handling by forced expression of SERCA2a in cardiomyocytes mitigates heart failure and arrhythmogenesis in a pig model for Duchenne muscular dystrophy (DMD). Methods and resultsMale offspring of pigs lacking DMD exon 52 are characterized by heart failure with reduced ejection fraction (HFrEF, EF 34.5{+/-}1.8% vs. 49.2{+/-}1.0% in control hearts), arrhythmogenesis due to large apical regions of reduced voltage amplitude and sudden cardiac death with a lifespan of usually less than 4 months. Slow antegrade intracoronary infusion of AAV1.SERCA2a (3x1013 virus genomes (vg) per pig) improved left ventricular ejection fraction (EF 47.3{+/-}2.0%, p<0.05) to a similar extent as germline editing of DMD{Delta}52 to DMD{Delta}51-52, inducing a Becker dystrophy (BMD) genotype (EF 46.7{+/-}3.8%). Moreover, AAV.SERCA2a significantly reduced myocardial inflammation and fibrosis and areas of reduced AP amplitude. ConclusionsIn DMD pigs, 3x1013vg/heart of GMP-grade AAV1.SERCA2a sufficed to normalize left ventricular function and improved electrical vulnerability of the heart. Hence, AAV.SERCA2a may serve as a treatment option for DMD cardiomyopathy.

physiology↗